Accordingly, myeloid-specific deletion of USP18, a negative regulator of type I IFN signaling, resulted in both increased infiltration of CD8+ T cells, especially central memory cells, into B16F10 melanomas and enhanced expression of activation markers (CD69, IFN-γ, perforin) in these T cells (85). Here, USP18 is linked to melanoma.